StockData
Becton Dickinson & Co logo

Becton Dickinson & Co (BDX) stock

BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3021% above fair value
$216.47−1.56 (-0.72%)

Close on Nov 16, 2026Market cap $58.96BP/E 65.4Yield 1.92%

Becton Dickinson r&d expenses

Research and development expenses are spending on new products and technology.

Becton Dickinson's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.37B, up 23.9% year over year. For fiscal 2025 it was $1.27B, up 6.3% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $1.28B in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Sep 30, 2025$1.27B+6.3%
FY2024Sep 30, 2024$1.19B-3.8%
FY2023Sep 30, 2023$1.24B-1.5%
FY2022Sep 30, 2022$1.26B-1.8%
FY2021Sep 30, 2021$1.28B+23.1%
FY2020Sep 30, 2020$1.04B-2.2%
FY2019Sep 30, 2019$1.06B+5.8%
FY2018Sep 30, 2018$1.00B+30.4%
FY2017Sep 30, 2017$770.00M-7.0%
FY2016Sep 30, 2016$828.00M+31.0%
FY2015Sep 30, 2015$632.00M+14.9%
FY2014Sep 30, 2014$550.00M+11.3%
FY2013Sep 30, 2013$494.00M+4.7%
FY2012Sep 30, 2012$472.00M+0.4%
FY2011Sep 30, 2011$470.00M+11.2%
FY2010Sep 30, 2010$422.77M+4.5%
FY2009Sep 30, 2009$404.57M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$258.00M+12.2%
Q2 FY2026CQ1 2026Mar 31, 2026$249.00M+7.3%
Q1 FY2026CQ4 2025Dec 31, 2025$306.00M-10.8%
Q4 FY2025CQ3 2025Sep 30, 2025$559.00M+85.1%
Q3 FY2025CQ2 2025Jun 30, 2025$230.00M-23.1%
Q2 FY2025CQ1 2025Mar 31, 2025$232.00M-22.4%
Q1 FY2025CQ4 2024Dec 31, 2024$343.00M+18.3%
Q4 FY2024CQ3 2024Sep 30, 2024$302.00M+7.5%
Q3 FY2024CQ2 2024Jun 30, 2024$299.00M-2.3%
Q2 FY2024CQ1 2024Mar 31, 2024$299.00M-11.3%
Q1 FY2024CQ4 2023Dec 31, 2023$290.00M-7.3%
Q4 FY2023CQ3 2023Sep 30, 2023$281.00M-6.3%
Q3 FY2023CQ2 2023Jun 30, 2023$306.00M-2.9%
Q2 FY2023CQ1 2023Mar 31, 2023$337.00M+3.1%
Q1 FY2023CQ4 2022Dec 31, 2022$313.00M-0.3%
Q4 FY2022CQ3 2022Sep 30, 2022$300.00M-18.5%
Q3 FY2022CQ2 2022Jun 30, 2022$315.00M-4.5%
Q2 FY2022CQ1 2022Mar 31, 2022$327.00M+3.2%
Q1 FY2022CQ4 2021Dec 31, 2021$314.00M+7.9%
Q4 FY2021CQ3 2021Sep 30, 2021$368.00M+52.1%
Q3 FY2021CQ2 2021Jun 30, 2021$330.00M+26.0%
Q2 FY2021CQ1 2021Mar 31, 2021$317.00M+20.1%
Q1 FY2021CQ4 2020Dec 31, 2020$291.00M+7.8%
Q4 FY2020CQ3 2020Sep 30, 2020$242.00M-10.4%
Q3 FY2020CQ2 2020Jun 30, 2020$262.00M-7.1%
Q2 FY2020CQ1 2020Mar 31, 2020$264.00M+4.8%
Q1 FY2020CQ4 2019Dec 31, 2019$270.00M+4.7%
Q4 FY2019CQ3 2019Sep 30, 2019$270.00M-2.5%
Q3 FY2019CQ2 2019Jun 30, 2019$282.00M+1.8%
Q2 FY2019CQ1 2019Mar 31, 2019$252.00M-2.7%
Q1 FY2019CQ4 2018Dec 31, 2018$258.00M+35.1%
Q4 FY2018CQ3 2018Sep 30, 2018$277.00M+28.2%
Q3 FY2018CQ2 2018Jun 30, 2018$277.00M+48.9%
Q2 FY2018CQ1 2018Mar 31, 2018$259.00M+38.5%
Q1 FY2018CQ4 2017Dec 31, 2017$191.00M+4.9%
Q4 FY2017CQ3 2017Sep 30, 2017$216.00M-14.6%
Q3 FY2017CQ2 2017Jun 30, 2017$186.00M–
Q2 FY2017CQ1 2017Mar 31, 2017$187.00M–
Q1 FY2017CQ4 2016Dec 31, 2016$182.00M–
Q4 FY2016CQ3 2016Sep 30, 2016$253.00M–

More Becton Dickinson figures

See a number that looks wrong?